Case Details

Decision Information

Decision Content

NOTE: Some of the documents on this web page have been provided by external sources and have been inserted, as received, in the language and format of record.
Questions or comments may be sent by e-mail to:
tribunal@ct-tc.gc.ca

 

CT-2023-007 (Apotex)

 

Apotex Inc. v Paladin Labs Inc. et al

Section(s):

s.103.1 - Leave to Make Application under Sections 75, 76, 77 or 79

Filed on:

2023-09-29

Status:

Withdrawn 2023-10-13

 

Applicant(s):

Apotex Inc.

Respondent(s):

Paladin Labs Inc.

Endo Pharmaceuticals Inc.

Takeda Canada Inc.

Takeda Pharmaceuticals U.S.A. Inc.

 

 

Case Documents

 

Pleading(s)

 

 

Decision(s)

 

 

Other(s)

 

#

Title

Date

15

Certification of the Commissioner pursuant to section 103.1

2023-10-04

 

 

 

 

 You are being directed to the most recent version of the statute which may not be the version considered at the time of the judgment.